• Genomics
  • Cell Based Assays
    • Cell Growth
    • Cell Dispensing
  • Gene Expression Analysis / Gene Discovery / Gene ID / Gene Characterization / Differential Display
    • Arraying/Plate printing
    • Array Hybridization
  • Drug Discovery
    • Compound Library Management
  • Assay Assembly
    • SNP SetUp
    • Genotyping
    • PCR
    • Sequencing
    • Taqman
  • DNA/RNA Synthesis
    • Oligo Synthesis
  • Sequencing
    • DNA Shearing (Prep for Sequencing)
    • Clone Production
    • Low Volume Sequencing
• Proteomics
  • Cell Based Research
    • Cell Growth
    • Cell Dispensing
  • Protein ID / Proteomics
    • Gel Imaging
    • Gel Analysis
    • Spot Excision
    • Protein Digestion
    • MS Sample Prep
  • Protein Structure
    • Protein Expression
    • Protein Crystallization
  • Protein Function
    • Protein Expression
    • Protein Arrays
    • Protein Assays
• Nanoliter Dispensing
  • Non-Contact
    • 98 or 384 Fixed Transfer
      25nl-1000nl
    • 1-17 Dispensers
      20nl-250μl
    • Customized Assays
  • Contact
    • 96 Well Fixed Dispense
      100nl-100μl

• Applications
• Instruments
• Consumables &
     OEM Parts
• Technical Library

• (US) ph: 877-436-6642
• (Int'l) ph: (+1) 734-975-4800
• info@genomicsolutions.com

News Release

Digilab, Inc. purchases Genomic Solutions, Inc. and MAIA Scientific

Dec. 3, 2007 -- Digilab, Inc. today announced it has completed the purchase of the Genomic Solutions and MAIA Scientific businesses from Harvard Bioscience NASDAQ: HBIO. The two businesses comprise the majority assets of HBIO's Capital Equipment Division with approximately $20 million in revenues.

Sidney Braginsky, Executive Chairman of Digilab, remarked "the acquisition of Harvard Biosciences Genomics Solutions and MAIA Scientific businesses broadens our global footprint in both the Life Sciences Research pre-analytics market and our commitment to provide downstream systems and solutions using novel sample preparation, biomarker, and spectroscopy methods for point of need applications in healthcare, process control, and safety and security markets. As has been true in the past, Digilab looks forward to solidifying and further expanding its customer and partner relationships to build the future value of Digilab's products and services."

About Digilab, Inc.

A global leader in molecular spectroscopy systems for over 40 years, Digilab provides innovative products and services for the life sciences research and in-vitro diagnostics markets including pharmaceutical and biotech industries as well as universities and governments. Digilab's primary focus is on sample preparation, bioinformatics, and detection/analysis tools enabling solutions for research and development featuring molecular spectroscopy methods.

Digilab acquired SpectraCode in West Lafayette Indiana, a technology leader in Raman Spectroscopy and developer of systems/solutions for portable "point of need" molecular spectroscopy identification. Digilab concluded an exclusive OEM Distribution Agreement with Boehringer Ingelheim Microparts under which it commercializes Boehringer Ingelheim proprietary MicroSystems Technology (MST) Microspectrometers. Digilab and Boehringer Ingelheim also have a cooperation to bring point of need molecular spectroscopy devices to the marketplace. Digilab acquired BioVisioN GmbH, now Digilab Peptidomics®. Digilab Peptidomics has developed and commercializes internationally patented Peptidomics® products and services. Digilab works with companies such as AstraZeneca, Boehringer Ingelheim, Merck & Co, Novartis, Novo Nordisk, Roche Diagnostics, Abbott Diagnostics, and Solvay Pharmaceuticals to address their needs for novel peptide biomarkers, diagnostics, and bioactive peptides for targeted therapeutics.